Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia

NCT02715726 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

615

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Alirocumab
DRUG: Placebo for alirocumab
DRUG: ezetimibe
DRUG: placebo for ezetimibe
DRUG: atorvastatin
DRUG: rosuvastatin
DRUG: simvastatin

Sponsor

Sanofi

Collaborators

[object Object]